RAAB G KIRK 4
4 · Transcept Pharmaceuticals Inc · Filed Feb 3, 2012
Insider Transaction Report
Form 4
RAAB G KIRK
Director
Transactions
- Award
Stock Option (right to buy)
2012-02-01+45,000→ 45,000 totalExercise: $8.09Exp: 2022-02-01→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The option vests in forty-eight equal monthly installments beginning February 24, 2012.